Duration of Dengue Viremia in Blood Donors and Relationships between Donor Viremia, Infection Incidence and Clinical Case Reports during a Large Epidemic

Journal of Infectious Diseases

Volumn 214, Issue 1, 2016, Pages 49-54

  Busch, Michael P ^a,b   Sabino, Ester C ^f,h   Brambilla, Donald ^e   Lopes, Maria Esther ^g,h   Capuani, Ligia ^f   Chowdhury, Dhuly ^e   McClure, Christopher ^e   Linnen, Jeffrey M ^c   Prince, Harry ^d   Simmons, Graham ^a,b   Lee, Tzong Hae ^a   Kleinman, Steven ^e   Custer, Brian ^a,b   De Almeida Neto, Cesar ^h   Mendrone Junior, Alfredo ^h   Carneiro Proietti, Anna Bárbara ^h   Sampaio, Divaldo De Almeida ^h   Loureiro, Paula ^h   Lobo, Clarisse ^h   Eduardo Ferreira, João ^h   Oikawa, Marcio ^h   Losco Takecian, Pedro ^h   Di Lorenzo Oliveira, Cláudia ^h   Kelly, Shannon ^h   Gonçalez, Thelma T ^h   Glynn, Simone A ^h   more..

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOLOGIC INC   (United States)

^d Focus Diagnostics   (United States)

^e RTI INTERNATIONAL   (United States)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g State Institute of Hematology Arthur de Siqueira Cavalcanti   (Brazil)

^h NONE

Author keywords

clinical symptoms; dengue; NAT; transfusion transmission

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NUCLEIC ACID; VIRUS RNA; VIRUS ANTIBODY;

BLOOD DONOR; BRAZIL; CONFERENCE PAPER; CONTROLLED STUDY; DENGUE; DISEASE DURATION; DISEASE TRANSMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; ADULT; AGED; ANIMAL; BLOOD; BLOOD TRANSFUSION; DENGUE VIRUS; EPIDEMIC; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MOSQUITO; SEROLOGY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; BRAZIL; CULICIDAE; DENGUE; DENGUE VIRUS; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEROLOGIC TESTS; VIREMIA;

EID: 84979247537     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw122     Document Type: Article

References (37)

1. Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol 2003; 3:19-28
2. Laughlin CA, Morens DM, Cassetti MC, et al. Dengue research opportunities in the Americas. J Infect Dis 2012; 206:1121-7
3. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004; 10:S98-109
4. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-96
5. World Health Organization. Dengue haemorrhagic fever, diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization, 1997
6. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010; 328:745-8
7. OhAinle M, Balmaseda A, Macalalad AR, et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 2011; 3:114ra128
8. Bianco C. Dengue and chikungunya viruses in blood donations: risks to the blood supply? Transfusion 2008; 48:1279-81
9. Petersen LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang 2010; 98:495-503
10. Chuang V,Wong TY, Leung YH, et al. Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008; 14:170-7
11. Tambyah PA, Koay ES, Poon ML, Lin RV, Ong BK. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008; 359:1526-7
12. Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012; 52:1657-66
13. Levi JE, Nishiya A, Felix AC, et al. Real-time symptomatic case of transfusiontransmitted dengue. Transfusion 2015; 55:961-4
14. Oh HB, Muthu V, Daruwalla ZJ, Lee SY, Koay ES, Tambyah PA. Bitten by a bug or a bag? transfusion-transmitted dengue: a rare complication in the bleeding surgical patient. Transfusion 2015; 55:1655-61
15. Matos D, Tomashek KM, Perez-Padilla J, et al. Probable and possible transfusiontransmitted dengue associated with NS1 antigen-negative but RNA confirmedpositive red blood cells. Transfusion 2016; 56:215-22
16. Dias LL, Amarilla AA, Poloni TR, Covas DT, Aquino VH, Figueiredo LT. Detection of dengue virus in sera of Brazilian blood donors. Transfusion 2012; 52:1667-71
17. Linnen JM, Vinelli E, Sabino EC, et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008; 48:1355-62
18. Mohammed H, Linnen JM, Munoz-Jordan JL, et al. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008; 48:1348-54
19. Teo D, Ng LC, Lam S. Is dengue a threat to the blood supply? Transfus Med 2009; 19:66-77
20. Wilder-Smith A, Chen LH, Massad E,Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis 2009; 15:8-11
21. Honorio NA, Nogueira RM, Codeco CT, et al. Spatial evaluation and modeling of dengue seroprevalence and vector density in Rio de Janeiro, Brazil. PLoS Negl Trop Dis 2009; 3:e545
22. Nunes MR, Faria NR, Vasconcelos HB, et al. Phylogeography of dengue virus serotype 4, Brazil, 2010-2011. Emerg Infect Dis 2012; 18:1858-64
23. Teixeira Mda G, Costa Mda C, Barreto ML, Mota E. Dengue and dengue hemorrhagic fever epidemics in Brazil: what research is needed based on trends, surveillance, and control experiences? Cad Saude Publica 2005; 21:1307-15
24. Sabino EC, Loureiro P, Lopes ME, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 2016; 213:694-702
25. Mattia K, Puffer BA, Williams KL, et al. Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 2011; 6:e27252
26. Oehlert GW. A note on the delta method. Am Stat 1992; 46:27-29
27. Chan M, Johansson MA. The incubation periods of dengue viruses. PLoS One 2012; 7:e50972
28. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 1981; 59:623-30
29. Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023-30
30. Carson PJ, Borchardt SM, Custer B, et al. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis 2012; 18: 684-6
31. Cervantes DT, Chen S, Sutor LJ, et al.West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012. Emerg Infect Dis 2015; 21:681-3
32. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, Busch MP. Estimated cumulative incidence ofWest Nile virus infection in US adults, 1999-2010. Epidemiol Infect 2013; 141:591-5
33. Petersen LR, Epstein JS. Chikungunya virus: new risk to transfusion safety in the Americas. Transfusion 2014; 54:1911-5
34. Petersen LR, Stramer SL, Powers AM. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010; 24:15-21
35. Carneiro-Proietti AB, Sabino EC, Sampaio D, et al. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion 2010; 50:918-25
36. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198:984-93
37. Busch MP, Wright DJ, Custer B, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 2006; 12:395-402